You are here: Home » News-CM » Companies » Results
Business Standard

Astrazeneca Pharma India standalone net profit declines 53.97% in the June 2017 quarter

Capital Market 

Sales decline 8.64% to Rs 127.48 crore

Net profit of declined 53.97% to Rs 5.80 crore in the quarter ended June 2017 as against Rs 12.60 crore during the previous quarter ended June 2016. Sales declined 8.64% to Rs 127.48 crore in the quarter ended June 2017 as against Rs 139.54 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales127.48139.54 -9 OPM %4.8912.86 -PBDT10.8819.57 -44 PBT7.1715.50 -54 NP5.8012.60 -54

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU